Explore News By Topic


Prostate Cancer Scoring Method May Underestimate Mortality Risk in Black Men

Original Press Release Issued by: Dana-Farber Cancer Institute Black men diagnosed with prostate cancer classified as low risk may actually have a more aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests. This... Read More


Reliance on ‘YouTube Medicine’ May Be Dangerous for Those Concerned About Prostate Cancer

Original Press Release Issued by: NYU Langone Health NOVEMBER 27, 2018 (9:30AM) The most popular YouTube videos on prostate cancer often offer misleading or biased medical information that poses potential health risks to patients, an analysis of the social media platform shows. Led by researchers at NYU School of Medicine and NYU... Read More


Baylor research team awarded $6.3 million NCI grant to develop tools to better understand disparities in prostate, breast cancers

Original Press Release Issued by: Baylor College of Medicine HOUSTON – (Oct. 3, 2018) – As part of the Beau Biden Cancer Moonshot initiative, the National Cancer Institute has awarded $6.3 million dollars to Dr. Nicholas Mitsiades and a multidisciplinary, collaborative team at Baylor College of Medicine to establish a... Read More


Clovis Oncology Receives Breakthrough Therapy Designation for Rubraca® (rucaparib) for Treatment of BRCA1/2-Mutated Metastatic Castration Resistant Prostate Cancer (mCRPC)

Breakthrough Therapy designation (BTD) granted to Rubraca based on initial data from ongoingTRITON2 Phase 2 study in advanced prostate cancer The data set from the TRITON2 study which supported BTD will be presented at the 2018 ESMO Congress later this month in Munich    BOULDER, Colo. (BUSINESS WIRE) -- October... Read More


MD Anderson Immunologist Jim Allison Awarded Nobel Prize

Original Press Release issued by: MD Anderson News Jim Allison, Ph.D., chair of Immunology and executive director of the Immunotherapy Platform at The University of Texas MD Anderson Cancer Center, today was awarded the 2018 Nobel Prize in Physiology or Medicine for launching an effective new way to attack cancer by treating the immune system... Read More


FinditParts Announces First Ever Matching Donation Campaign in Commercial Vehicle Industry to Raise Funds And Awareness for Prostate Cancer Research

LOS ANGELES (Sept. 12, 2018) -- FinditParts, the number one supplier of heavy duty truck and trailer parts online, today pledged its commitment to the Prostate Cancer Foundation’s (PCF) community fundraising initiative, Many vs Cancer, to match 100 percent of donations made through its website beginning in September which is... Read More


Immunotherapy could offer hope for some men with aggressive prostate cancers

Original Press Release issued by: The Institute of Cancer Research, London Study finds that a subset of men with prostate cancer have ‘mismatch’ DNA repair defects in their tumours These men have very aggressive disease with worse survival on currently available therapies BUT are more likely to benefit from immunotherapy New... Read More


Genomic Landscape of Metastatic Prostate Cancer Unveiled in New Study

A comprehensive genetic analysis of metastatic prostate cancer has, for the first time, revealed a number of major ways in which abnormal alterations of the genome propel this aggressive form of the disease. As reported in the July 19, 2018 issue of Cell, a team led by investigators at UC... Read More


NIH and Prostate Cancer Foundation launch large study on aggressive prostate cancer in African-American men

The largest coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men has begun. The $26.5 million study is called RESPOND, or Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Tumor Markers, and Social Stress. It will... Read More


Deadly Form of Advanced Prostate Cancer is Common, Calls for Distinct Treatment

Original article issued by UCSF News. A new study of prostate cancer in 202 men, whose cancers had spread and were resistant to standard treatment, found that a surprisingly large number of these cancers – about 17 percent – belong to a deadlier subtype of metastatic prostate cancer. Previously, it... Read More